Loading clinical trials...
Loading clinical trials...
Herlitz junctional epidermolysis bullosa (H-JEB), an incurable, fatal, inherited skin disease, is caused by loss-of-function mutations in the LAMA3, LAMB3 or LAMC2 genes, resulting in loss of laminin ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Southern California
NCT06713434 · Junctional Epidermolysis Bullosa, Epidermolysis Bullosa (EB), and more
NCT05111600 · Junctional Epidermolysis Bullosa Non-Herlitz Type
NCT03578029 · Junctional Epidermolysis Bullosa, Dystrophic Epidermolysis Bullosa
NCT04727268 · Junctional Epidermolysis Bullosa, Laryngo Onycho Cutaneous Syndrome
University of Southern California
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions